Viral-guided hepatitis C therapy

Fred Poordad, Nancy Reau

Resultado de la investigación: Review articlerevisión exhaustiva


Predicting hepatitis C treatment outcomes is of great benefit to patient and clinician. Baseline predictors of response or failure can set the appropriate expectations for the patient and may aid in decision making about starting therapy. An accurate assessment of the potential for treatment success involves using rapid and early viral kinetics at weeks 4 and 12. These time points are useful to set up stopping rules and to provide motivation for the patient and health care provider to continue when appropriate. Relapse is an unfortunate consequence of therapy in a significant number of patients. Baseline and on-treatment viral assessments are useful in helping predict and perhaps reduce this phenomenon.

Idioma originalEnglish (US)
Páginas (desde-hasta)66-72
Número de páginas7
PublicaciónCurrent Hepatitis Reports
EstadoPublished - may 19 2009
Publicado de forma externa

ASJC Scopus subject areas

  • Hepatology
  • Virology


Profundice en los temas de investigación de 'Viral-guided hepatitis C therapy'. En conjunto forman una huella única.

Citar esto